Angiotensinamide is octapeptide amide of bovine angiotensin II used to increase blood pressure by vasoconstriction. Angiotensinamide is indicated for the treatment of severe hypotension unresponsive to traditional pressor agents. Angiotensinamide has a strong pressure effect, due to the increased peripheral resistance of blood vessels, especially small caliber arterioles. Under the influence of angiotensinamide, the vessels of the internal organs, skin, kidneys are particularly narrowed. Blood circulation in skeletal muscles and coronary vessels does not change significantly. The drug has no direct effect on the heart and does not cause arrhythmias in therapeutic doses. Angiotensinamide is rapidly inactivated by enzymes contained in the blood, and therefore, when administered once, it has a short-term (2–3 min) pressure effect. However, the duration of the effect can be relatively easily controlled by selecting the appropriate rate of administration of the drug solution.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
C01CX06
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
||
|
NCI_THESAURUS |
C548
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
||
|
WHO-VATC |
QC01CX06
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
107678
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
DB13517
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
m1914
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID401018923
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
7WAL1X78KV
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
SUB05511MIG
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
53-73-6
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
2719
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
4338
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
10351092
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
CHEMBL409803
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
200-182-3
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
1057
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
ANGIOTENSINAMIDE
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY | |||
|
C77008
Created by
admin on Sat Dec 16 01:00:10 UTC 2023 , Edited by admin on Sat Dec 16 01:00:10 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
